8Aug2018 The Antibiotic Opportunity? Spero’s Ankit Mahadevia on The Long Run Podcast /Luke Timmerman/2/All08 Aug 2018 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.